No annual revenue total was found in NOMAD POWER SOLUTIONS, INC.'s SEC filings.
Nomad Power Solutions, Inc. (NMAD) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $12.7 million in cash and investments and $1.1 million in total debt.
Revenue
—
Net income
$-6.08M
-69.5% vs prior year
Operating cash flow (TTM)
$-5.46M
-108.9% vs year-ago TTM
Free cash flow
—
EPS
$-1.26
+20.8% vs prior year
Dividend per share
None
Shares outstanding
11.62M
+332.8% vs prior year
Net cash
$11.57M
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NMAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1335105
- Former names
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (until Jul 2, 2026); SRKP 7 INC (until Dec 1, 2006)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$5.1M | -$3.6M | -$5.1M | -$6.3M | -$6.7M |
| Net income | -$6.1M | -$3.6M | -$5.1M | -$6.3M | -$6.7M |
| Diluted EPS | -$1.26 | -$1.59 | -$2.66 | — | — |
| Operating cash flow | -$3.1M | -$3.2M | -$4.3M | -$4.6M | -$4.1M |
| Total assets | $12.7M | $1.1M | $4.3M | $5.6M | $5.1M |
| Total liabilities | $1.8M | — | — | — | — |
| Stockholders' equity | $9.7M | $827,219 | $4.0M | $5.2M | $4.8M |
| Cash and investments | $5.1M | $1.0M | — | — | — |
| Total debt | $1.0M | — | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 30, 2026 | Sep 28, 2026 |
| 8-K/A | Amended current report | Sep 17, 2026 | Jul 1, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2026 | Jul 8, 2026 |
All 528 Nomad Power Solutions, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.